Skip to main content
Clinical Trials/ChiCTR2200064634
ChiCTR2200064634
Not yet recruiting
Early Phase 1

基于冠脉造影的微循环阻力指数在行 PCI 术冠心病患者的诊断和预后方面的临床应用价值

由苏州润迈德医疗科技有限公司资助1 site in 1 countryStarted: September 1, 2022Last updated:

Overview

Phase
Early Phase 1
Status
Not yet recruiting
Sponsor
由苏州润迈德医疗科技有限公司资助
Locations
1
Primary Endpoint
基于冠脉造影的微循环阻力指数

Overview

Brief Summary

旨在运用 caIMR 系统评估接受 PCI 治疗的冠心病患者治疗效果及预后。

Study Design

Study Type
诊断试验
Primary Purpose
连续入组

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • 临床诊断为稳定型冠心病且拟行心脏支架植入术的患者

Exclusion Criteria

  • 1.患者病情不稳定;2.既往曾行心脏搭桥术或者心脏支架植入术患者;

Outcomes

Primary Outcomes

基于冠脉造影的微循环阻力指数

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
由苏州润迈德医疗科技有限公司资助

Study Sites (1)

Loading locations...

Similar Trials